These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23077406)

  • 1. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
    Rossmiller B; Mao H; Lewin AS
    Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
    Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
    Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
    Sudharsan R; Beltran WA
    Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.
    Mao H; Gorbatyuk MS; Hauswirth WW; Lewin AS
    Adv Exp Med Biol; 2012; 723():199-205. PubMed ID: 22183334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
    O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
    Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
    Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
    EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-based therapies for dominantly inherited retinopathies.
    Farrar GJ; Millington-Ward S; Chadderton N; Humphries P; Kenna PF
    Gene Ther; 2012 Feb; 19(2):137-44. PubMed ID: 22089493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
    O'Reilly M; Palfi A; Chadderton N; Millington-Ward S; Ader M; Cronin T; Tuohy T; Auricchio A; Hildinger M; Tivnan A; McNally N; Humphries MM; Kiang AS; Humphries P; Kenna PF; Farrar GJ
    Am J Hum Genet; 2007 Jul; 81(1):127-35. PubMed ID: 17564969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of dominant mutations of rhodopsin and implications for gene therapy.
    Wilson JH; Wensel TG
    Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
    Meng D; Ragi SD; Tsang SH
    Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
    Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
    Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
    Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
    Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
    Du W; Li J; Tang X; Yu W; Zhao M
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
    Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
    Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
    Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
    FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant retinitis pigmentosa rhodopsin mutant Q344X drives specific alterations in chromatin complex gene transcription.
    Bales KL; Ianov L; Kennedy AJ; Sweatt JD; Gross AK
    Mol Vis; 2018; 24():153-164. PubMed ID: 29463953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
    Millington-Ward S; Chadderton N; O'Reilly M; Palfi A; Goldmann T; Kilty C; Humphries M; Wolfrum U; Bennett J; Humphries P; Kenna PF; Farrar GJ
    Mol Ther; 2011 Apr; 19(4):642-9. PubMed ID: 21224835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
    Mitra RN; Zheng M; Weiss ER; Han Z
    Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene augmentation for adRP mutations in RHO.
    Lewin AS; Rossmiller B; Mao H
    Cold Spring Harb Perspect Med; 2014 Jul; 4(9):a017400. PubMed ID: 25037104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.